Cerebral malaria: Utah study identifies a potential drug target
by Press Release from Outbreak News Today on (#4Z3RY)
Scientists have identified a key molecule involved in the development of cerebral malaria, a deadly form of the tropical disease. The study identifies a potential drug target and way forward toward alleviating this condition for which few targeted treatments are available. In studies with mice, investigators discovered that the EphA2 protein is important for onset ["]
The post Cerebral malaria: Utah study identifies a potential drug target appeared first on Outbreak News Today.